Deutsche Bundesstiftung Umwelt: Construction of a recombinant biocatalyst for the production of phenylacetic acids and phenylethanols from styrenes

Sarah Hofmann, Anna Drechsel, Michael Schlömann, and Michel Oelschlägel

DBU

Abstract:

Numerous soil bacteria have been reported to be able to metabolize styrene via the pathway of sidechain oxygenation. This pathway comprises a styrene monooxygenase (SMO), which oxidizes styrene to styrene oxide, a styrene oxide isomerase (SOI), which converts styrene oxide into phenylacetaldehyde, and a phenylacetaldehyde dehydrogenase (PAD). The latter enzyme enables the oxidation of the aldehyde to the central metabolite phenylacetic acid [1]. In this study the construction of a recombinant biocatalyst under consideration of suitable SMOs, SOIs and PADs was intended because this pathway is of potential relevance for the biotechnological production of phenylacetic acids and similar compounds.

Want to know more about this publication? Contact our scientists

Medicinal chemistry

Drug Discovery

Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular…

custom chemical services

Custom Synthesis

We support our customers by providing first kg quantities of fine and specialty chemicals, cost reduction of existing syntheses, streamlining chemical processes considering…

Looks interesting?

As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.
Scroll to Top